Publication | Closed Access
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)
54
Citations
5
References
2013
Year
These are the first real-world data using BVS in patients with STEMI. The ABSORB™ BVS may be safely used in patients with STEMI undergoing primary PCI with favourable short-term outcome.
| Year | Citations | |
|---|---|---|
Page 1
Page 1